Evidence map›Paper›PMID 40880576›Full record

ReviewWorld journal of critical care medicine2025

Klotho: A multifaceted protector in sepsis-induced organ damage and a potential therapeutic target.

Alaa Al-Kadi, Aliaa Anter, Remon R Rofaeil, Mohamed M Sayed-Ahmed, Al-Shaimaa F Ahmed

Abstract readReview
In one paragraph

Review in World journal of critical care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alaa Al-KadiDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Deraya University, Minia 61511, Egypt.
Aliaa AnterDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia 61511, Egypt.
Remon R RofaeilDepartment of Medical Pharmacology, Faculty of Medicine, Minia University, Minia 61511, Egypt.
Mohamed M Sayed-AhmedPharmacology and Experimental Oncology Unit, National Cancer Institute, Cairo University, Cairo 11435, Egypt.
Al-Shaimaa F AhmedDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia 61511, Egypt. shaimaa.faissal@minia.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a life-threatening organ dysfunction associated with a robust systemic inflammatory and immune response to infection. Its pathological consequences lead to multiple organ deficits. Klotho was initially introduced as an antiaging molecule. Its deficiency significantly reduces lifespan, and its overexpression protects against organ injury. It reduces oxidative stress and apoptosis and has anti-inflammatory and antifibrotic properties. In this review, we discuss the underlying mechanisms of sepsis-related klotho down-regulation and the protective role of klotho in sepsis. In developing sepsis-induced multiple organ damage, klotho can modulate multiple downstream signals including nuclear factor-kappa β, mitogen activated protein kinase, and apoptosis. Multiple studies show klotho's protective effects in sepsis through activation of nuclear factor erythroid-related factor 2, Forkhead transcription factor O, and restoration of internal antioxidant activity. The proposed protective action of klotho is a promising therapeutic strategy for managing sepsis and ameliorating its related organ damage.

Indexed as

AgingCell signalingInflammationKlothoOxidationSepsis

Identifiers

PMID40880576
PMCPMC12305058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.